http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-057881-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438 |
| filingDate | 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75777826be4bf9ab40aab1c282de4763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2cfde9d9722b8690e1aa138cbba8ef9 |
| publicationDate | 2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-057881-A1 |
| titleOfInvention | DERIVATIVES OF 2- (BENCIMIDAZOL-1-IL) -N-BIARIL-ACETAMIDE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF MEDIATIONS BY TRPV1 |
| abstract | Biaryl derivatives of 2- (benzimidazol-1-yl) acetamide having the general formula (1) where n is 0 or 1; Ar1 represents a di-radical derived from a 5 or 6 membered aromatic ring, which optionally comprises 1-3 heteroatoms selected from N, O and S, said ring being optionally substituted with (C1-4) alkyl, (C1-4) -alkyloxy, halogen, CF3 or cyano; Ar2 represents a 6-membered aryl ring that optionally comprises 1-3 nitrogen atoms, said ring being optionally substituted with 1-3 substituents selected from (1-4) alkyl (optionally substituted with 1 or more halogens), (C1-4 ) alkyloxy (optionally substituted with 1 or more halogens), di (C1-4-alkylamino, halogen, CF3 or cyano; or a pharmaceutically acceptable salt thereof; to pharmaceutical compositions comprising them, or to the use of said bisaryl derivatives of 2- (Benzimidazol-1-yl) -acetamide in the treatment of disorders mediated by TRPV1. |
| priorityDate | 2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.